Kiniksa Pharmaceuticals International (KNSA) EBITDA (2017 - 2026)
Kiniksa Pharmaceuticals International (KNSA) posted EBITDA of $27.67 million for Q2 2026, up 34.8% from $20.52 million a year earlier but down 7.0% from the prior quarter.
Powered by 
Analysis
Kiniksa Pharmaceuticals International (KNSA) EBITDA (2017 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA at Kiniksa Pharmaceuticals International was $102.04 million; for FY2025, it came in at $78.78 million.
- In prior years, Kiniksa Pharmaceuticals International's EBITDA was -$43.92 million in FY2024, -$22.86 million in FY2023, $12.18 million in FY2022 and -$154.28 million in FY2021.
- Quarterly EBITDA has run from a low of -$35.46 million in Q4 2021 to a high of $46.91 million in Q3 2022 over five years.
- According to Business Quant data, EBITDA for the three prior quarters was $29.74 million (Q1 2026), $20.24 million (Q4 2025) and $24.41 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Kiniksa Pharmaceuticals International | 6.23 Bn | 4.97 Bn | 220.03 Mn | 27.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.67 Mn |
| Mar 31, 2026 | 29.74 Mn |
| Dec 31, 2025 | 20.24 Mn |
| Sep 30, 2025 | 24.41 Mn |
| Jun 30, 2025 | 20.52 Mn |
| Mar 31, 2025 | 13.62 Mn |
| Dec 31, 2024 | -18.90 Mn |
| Sep 30, 2024 | -9.26 Mn |
| Jun 30, 2024 | 313,000.00 |
| Mar 31, 2024 | -16.08 Mn |
| Dec 31, 2023 | 621,000.00 |
| Sep 30, 2023 | -10.32 Mn |
| Jun 30, 2023 | -2.55 Mn |
| Mar 31, 2023 | -10.60 Mn |
| Dec 31, 2022 | 6.65 Mn |
| Sep 30, 2022 | 46.91 Mn |
| Jun 30, 2022 | -18.72 Mn |
| Mar 31, 2022 | -22.66 Mn |
| Dec 31, 2021 | -35.46 Mn |
| Sep 30, 2021 | -30.01 Mn |
API Access
Kiniksa Pharmaceuticals International EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=KNSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "KNSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=KNSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();